Infection with Human T Lymphotropic Virus Types I and II in Sexually Transmitted Disease Clinics in Baltimore and New Orleans

Patients attending sexually transmitted disease (STD) clinics in Baltimore (n = 4880) and New Orleans (n = 1054) were surveyed in 1987 to estimate the prevalence of human T lymphotropic virus (HTLV)-I/II infection. In Baltimore, 0.4% (95% confidence interval [CI], 0.2–1.1) were HTLV-I/II-seropositiv...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of infectious diseases 1992-05, Vol.165 (5), p.920-924
Hauptverfasser: Wiktor, Stefan Z., Cannon, Robert O., Atkinson, William L., Lutz, Brobson, Hook, Edward W., Blattner, William A., Quinn, Thomas C.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 924
container_issue 5
container_start_page 920
container_title The Journal of infectious diseases
container_volume 165
creator Wiktor, Stefan Z.
Cannon, Robert O.
Atkinson, William L.
Lutz, Brobson
Hook, Edward W.
Blattner, William A.
Quinn, Thomas C.
description Patients attending sexually transmitted disease (STD) clinics in Baltimore (n = 4880) and New Orleans (n = 1054) were surveyed in 1987 to estimate the prevalence of human T lymphotropic virus (HTLV)-I/II infection. In Baltimore, 0.4% (95% confidence interval [CI], 0.2–1.1) were HTLV-I/II-seropositive and 4.9% were human immunodeficiency virus (HIV-1)-positive. In New Orleans, 1.8% (CI, 1.2–2.9) of sera were HTLV-I/II-seropositive and 5.1% were HIV-I-seropositive. In both cities, HTLV-I/II prevalence increased significantly with age, and the New Orleans age- and sex-adjusted HTLV-I/II prevalence was significantly higher than that of Baltimore (P < .001). In Baltimore, almost all HTLV-I/II seropositivity was associated with a history of parenteral drug use or sexual contact with partners who were drug users or male homosexuals. In addition, individuals in both cities who were seropositive for HIV-lor syphilis were significantly more likely to be HTLV-I/II-seropositive.
doi_str_mv 10.1093/infdis/165.5.920
format Article
fullrecord <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_16843324</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>30112152</jstor_id><sourcerecordid>30112152</sourcerecordid><originalsourceid>FETCH-LOGICAL-c300t-113868f76047261c893814952d800f7951d12999dac8317ed5c1191e99085d853</originalsourceid><addsrcrecordid>eNpFkLFv1DAUhy0EKkdhZ0HyxJarnx079ggH5SKdqAShQl0s4ziqS-IE21F7A_87Kana6Q3f73vDh9BbIFsgip350LU-nYHgW75VlDxDG-CsKoQA9hxtCKG0AKnUS_QqpRtCSMlEdYJOgAvFynKD_tahczb7MeBbn6_xfh5MwA0-HIfpesxxnLzFlz7OCTfHySVcYxNaXNfYB_zd3c2m74-4iSakwefsWvzJJ2eSw7veB2_T_e6j6bMfxuj-u1_dLb6IvVuU1-hFZ_rk3jzcU_Tj_HOz2xeHiy_17sOhsIyQXAAwKWRXCVJWVICVikkoFaetJKSrFIcWqFKqNVYyqFzLLYACpxSRvJWcnaL3698pjn9ml7IefLKu701w45w0CFkyRstlSNahjWNK0XV6in4w8aiB6Pviei2-GFxzvRRflHcPv-dfg2ufhDXxE79JeYyPmBEACpwuvFi5T9ndPXITf2tRsYrr_c8rza4OXDTfzvUl-wf6EpVD</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16843324</pqid></control><display><type>article</type><title>Infection with Human T Lymphotropic Virus Types I and II in Sexually Transmitted Disease Clinics in Baltimore and New Orleans</title><source>MEDLINE</source><source>JSTOR Archive Collection A-Z Listing</source><creator>Wiktor, Stefan Z. ; Cannon, Robert O. ; Atkinson, William L. ; Lutz, Brobson ; Hook, Edward W. ; Blattner, William A. ; Quinn, Thomas C.</creator><creatorcontrib>Wiktor, Stefan Z. ; Cannon, Robert O. ; Atkinson, William L. ; Lutz, Brobson ; Hook, Edward W. ; Blattner, William A. ; Quinn, Thomas C.</creatorcontrib><description>Patients attending sexually transmitted disease (STD) clinics in Baltimore (n = 4880) and New Orleans (n = 1054) were surveyed in 1987 to estimate the prevalence of human T lymphotropic virus (HTLV)-I/II infection. In Baltimore, 0.4% (95% confidence interval [CI], 0.2–1.1) were HTLV-I/II-seropositive and 4.9% were human immunodeficiency virus (HIV-1)-positive. In New Orleans, 1.8% (CI, 1.2–2.9) of sera were HTLV-I/II-seropositive and 5.1% were HIV-I-seropositive. In both cities, HTLV-I/II prevalence increased significantly with age, and the New Orleans age- and sex-adjusted HTLV-I/II prevalence was significantly higher than that of Baltimore (P &lt; .001). In Baltimore, almost all HTLV-I/II seropositivity was associated with a history of parenteral drug use or sexual contact with partners who were drug users or male homosexuals. In addition, individuals in both cities who were seropositive for HIV-lor syphilis were significantly more likely to be HTLV-I/II-seropositive.</description><identifier>ISSN: 0022-1899</identifier><identifier>EISSN: 1537-6613</identifier><identifier>DOI: 10.1093/infdis/165.5.920</identifier><identifier>PMID: 1569344</identifier><language>eng</language><publisher>United States: The University of Chicago Press</publisher><subject>Adolescent ; Adult ; Age Factors ; Baltimore - epidemiology ; Concise Communications ; Female ; HIV ; HIV 1 ; HIV Antibodies - blood ; HIV Infections - epidemiology ; HIV-1 - immunology ; HTLV-I Antibodies - blood ; HTLV-I Infections - epidemiology ; HTLV-II Antibodies - blood ; HTLV-II Infections - epidemiology ; Human T lymphotropic virus 1 ; Human T lymphotropic virus 2 ; Humans ; Infections ; Louisiana - epidemiology ; Male ; Male homosexuality ; Men ; Prevalence ; Risk Factors ; Sexually transmitted diseases ; Sexually Transmitted Diseases - epidemiology ; Substance Abuse, Intravenous - complications ; Syphilis ; Viruses</subject><ispartof>The Journal of infectious diseases, 1992-05, Vol.165 (5), p.920-924</ispartof><rights>Copyright 1992 The University of Chicago</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c300t-113868f76047261c893814952d800f7951d12999dac8317ed5c1191e99085d853</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/30112152$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/30112152$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,780,784,803,27924,27925,58017,58250</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1569344$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wiktor, Stefan Z.</creatorcontrib><creatorcontrib>Cannon, Robert O.</creatorcontrib><creatorcontrib>Atkinson, William L.</creatorcontrib><creatorcontrib>Lutz, Brobson</creatorcontrib><creatorcontrib>Hook, Edward W.</creatorcontrib><creatorcontrib>Blattner, William A.</creatorcontrib><creatorcontrib>Quinn, Thomas C.</creatorcontrib><title>Infection with Human T Lymphotropic Virus Types I and II in Sexually Transmitted Disease Clinics in Baltimore and New Orleans</title><title>The Journal of infectious diseases</title><addtitle>J Infect Dis</addtitle><description>Patients attending sexually transmitted disease (STD) clinics in Baltimore (n = 4880) and New Orleans (n = 1054) were surveyed in 1987 to estimate the prevalence of human T lymphotropic virus (HTLV)-I/II infection. In Baltimore, 0.4% (95% confidence interval [CI], 0.2–1.1) were HTLV-I/II-seropositive and 4.9% were human immunodeficiency virus (HIV-1)-positive. In New Orleans, 1.8% (CI, 1.2–2.9) of sera were HTLV-I/II-seropositive and 5.1% were HIV-I-seropositive. In both cities, HTLV-I/II prevalence increased significantly with age, and the New Orleans age- and sex-adjusted HTLV-I/II prevalence was significantly higher than that of Baltimore (P &lt; .001). In Baltimore, almost all HTLV-I/II seropositivity was associated with a history of parenteral drug use or sexual contact with partners who were drug users or male homosexuals. In addition, individuals in both cities who were seropositive for HIV-lor syphilis were significantly more likely to be HTLV-I/II-seropositive.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Age Factors</subject><subject>Baltimore - epidemiology</subject><subject>Concise Communications</subject><subject>Female</subject><subject>HIV</subject><subject>HIV 1</subject><subject>HIV Antibodies - blood</subject><subject>HIV Infections - epidemiology</subject><subject>HIV-1 - immunology</subject><subject>HTLV-I Antibodies - blood</subject><subject>HTLV-I Infections - epidemiology</subject><subject>HTLV-II Antibodies - blood</subject><subject>HTLV-II Infections - epidemiology</subject><subject>Human T lymphotropic virus 1</subject><subject>Human T lymphotropic virus 2</subject><subject>Humans</subject><subject>Infections</subject><subject>Louisiana - epidemiology</subject><subject>Male</subject><subject>Male homosexuality</subject><subject>Men</subject><subject>Prevalence</subject><subject>Risk Factors</subject><subject>Sexually transmitted diseases</subject><subject>Sexually Transmitted Diseases - epidemiology</subject><subject>Substance Abuse, Intravenous - complications</subject><subject>Syphilis</subject><subject>Viruses</subject><issn>0022-1899</issn><issn>1537-6613</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1992</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkLFv1DAUhy0EKkdhZ0HyxJarnx079ggH5SKdqAShQl0s4ziqS-IE21F7A_87Kana6Q3f73vDh9BbIFsgip350LU-nYHgW75VlDxDG-CsKoQA9hxtCKG0AKnUS_QqpRtCSMlEdYJOgAvFynKD_tahczb7MeBbn6_xfh5MwA0-HIfpesxxnLzFlz7OCTfHySVcYxNaXNfYB_zd3c2m74-4iSakwefsWvzJJ2eSw7veB2_T_e6j6bMfxuj-u1_dLb6IvVuU1-hFZ_rk3jzcU_Tj_HOz2xeHiy_17sOhsIyQXAAwKWRXCVJWVICVikkoFaetJKSrFIcWqFKqNVYyqFzLLYACpxSRvJWcnaL3698pjn9ml7IefLKu701w45w0CFkyRstlSNahjWNK0XV6in4w8aiB6Pviei2-GFxzvRRflHcPv-dfg2ufhDXxE79JeYyPmBEACpwuvFi5T9ndPXITf2tRsYrr_c8rza4OXDTfzvUl-wf6EpVD</recordid><startdate>199205</startdate><enddate>199205</enddate><creator>Wiktor, Stefan Z.</creator><creator>Cannon, Robert O.</creator><creator>Atkinson, William L.</creator><creator>Lutz, Brobson</creator><creator>Hook, Edward W.</creator><creator>Blattner, William A.</creator><creator>Quinn, Thomas C.</creator><general>The University of Chicago Press</general><general>University of Chicago Press</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U9</scope><scope>H94</scope></search><sort><creationdate>199205</creationdate><title>Infection with Human T Lymphotropic Virus Types I and II in Sexually Transmitted Disease Clinics in Baltimore and New Orleans</title><author>Wiktor, Stefan Z. ; Cannon, Robert O. ; Atkinson, William L. ; Lutz, Brobson ; Hook, Edward W. ; Blattner, William A. ; Quinn, Thomas C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c300t-113868f76047261c893814952d800f7951d12999dac8317ed5c1191e99085d853</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1992</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Age Factors</topic><topic>Baltimore - epidemiology</topic><topic>Concise Communications</topic><topic>Female</topic><topic>HIV</topic><topic>HIV 1</topic><topic>HIV Antibodies - blood</topic><topic>HIV Infections - epidemiology</topic><topic>HIV-1 - immunology</topic><topic>HTLV-I Antibodies - blood</topic><topic>HTLV-I Infections - epidemiology</topic><topic>HTLV-II Antibodies - blood</topic><topic>HTLV-II Infections - epidemiology</topic><topic>Human T lymphotropic virus 1</topic><topic>Human T lymphotropic virus 2</topic><topic>Humans</topic><topic>Infections</topic><topic>Louisiana - epidemiology</topic><topic>Male</topic><topic>Male homosexuality</topic><topic>Men</topic><topic>Prevalence</topic><topic>Risk Factors</topic><topic>Sexually transmitted diseases</topic><topic>Sexually Transmitted Diseases - epidemiology</topic><topic>Substance Abuse, Intravenous - complications</topic><topic>Syphilis</topic><topic>Viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wiktor, Stefan Z.</creatorcontrib><creatorcontrib>Cannon, Robert O.</creatorcontrib><creatorcontrib>Atkinson, William L.</creatorcontrib><creatorcontrib>Lutz, Brobson</creatorcontrib><creatorcontrib>Hook, Edward W.</creatorcontrib><creatorcontrib>Blattner, William A.</creatorcontrib><creatorcontrib>Quinn, Thomas C.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>The Journal of infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wiktor, Stefan Z.</au><au>Cannon, Robert O.</au><au>Atkinson, William L.</au><au>Lutz, Brobson</au><au>Hook, Edward W.</au><au>Blattner, William A.</au><au>Quinn, Thomas C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Infection with Human T Lymphotropic Virus Types I and II in Sexually Transmitted Disease Clinics in Baltimore and New Orleans</atitle><jtitle>The Journal of infectious diseases</jtitle><addtitle>J Infect Dis</addtitle><date>1992-05</date><risdate>1992</risdate><volume>165</volume><issue>5</issue><spage>920</spage><epage>924</epage><pages>920-924</pages><issn>0022-1899</issn><eissn>1537-6613</eissn><abstract>Patients attending sexually transmitted disease (STD) clinics in Baltimore (n = 4880) and New Orleans (n = 1054) were surveyed in 1987 to estimate the prevalence of human T lymphotropic virus (HTLV)-I/II infection. In Baltimore, 0.4% (95% confidence interval [CI], 0.2–1.1) were HTLV-I/II-seropositive and 4.9% were human immunodeficiency virus (HIV-1)-positive. In New Orleans, 1.8% (CI, 1.2–2.9) of sera were HTLV-I/II-seropositive and 5.1% were HIV-I-seropositive. In both cities, HTLV-I/II prevalence increased significantly with age, and the New Orleans age- and sex-adjusted HTLV-I/II prevalence was significantly higher than that of Baltimore (P &lt; .001). In Baltimore, almost all HTLV-I/II seropositivity was associated with a history of parenteral drug use or sexual contact with partners who were drug users or male homosexuals. In addition, individuals in both cities who were seropositive for HIV-lor syphilis were significantly more likely to be HTLV-I/II-seropositive.</abstract><cop>United States</cop><pub>The University of Chicago Press</pub><pmid>1569344</pmid><doi>10.1093/infdis/165.5.920</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-1899
ispartof The Journal of infectious diseases, 1992-05, Vol.165 (5), p.920-924
issn 0022-1899
1537-6613
language eng
recordid cdi_proquest_miscellaneous_16843324
source MEDLINE; JSTOR Archive Collection A-Z Listing
subjects Adolescent
Adult
Age Factors
Baltimore - epidemiology
Concise Communications
Female
HIV
HIV 1
HIV Antibodies - blood
HIV Infections - epidemiology
HIV-1 - immunology
HTLV-I Antibodies - blood
HTLV-I Infections - epidemiology
HTLV-II Antibodies - blood
HTLV-II Infections - epidemiology
Human T lymphotropic virus 1
Human T lymphotropic virus 2
Humans
Infections
Louisiana - epidemiology
Male
Male homosexuality
Men
Prevalence
Risk Factors
Sexually transmitted diseases
Sexually Transmitted Diseases - epidemiology
Substance Abuse, Intravenous - complications
Syphilis
Viruses
title Infection with Human T Lymphotropic Virus Types I and II in Sexually Transmitted Disease Clinics in Baltimore and New Orleans
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T06%3A03%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Infection%20with%20Human%20T%20Lymphotropic%20Virus%20Types%20I%20and%20II%20in%20Sexually%20Transmitted%20Disease%20Clinics%20in%20Baltimore%20and%20New%20Orleans&rft.jtitle=The%20Journal%20of%20infectious%20diseases&rft.au=Wiktor,%20Stefan%20Z.&rft.date=1992-05&rft.volume=165&rft.issue=5&rft.spage=920&rft.epage=924&rft.pages=920-924&rft.issn=0022-1899&rft.eissn=1537-6613&rft_id=info:doi/10.1093/infdis/165.5.920&rft_dat=%3Cjstor_proqu%3E30112152%3C/jstor_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16843324&rft_id=info:pmid/1569344&rft_jstor_id=30112152&rfr_iscdi=true